How many babies would be eligible each year for the meningitis B vaccine if it was included in the national immunisation programme. 

The Joint Committee on Vaccination and Immunisation (JCVI) has recommended that there should be a national meningococcal B immunisation programme for infants using a three dose schedule of Bexsero (at two, four and 12 months of age), subject to the vaccine being available at a cost-effective price.
If the vaccine can be procured at a cost-effective price, and the meningitis B vaccine is introduced into the routine infant immunisation programme, then at the point of introduction all babies in Scotland attending for their routine two month vaccination appointment would also receive the meningitis B vaccine. We estimate around 60,000 babies will be eligible each year.
The JCVI has also advised that if the programme is introduced there should be a one-off, opportunistic catch-up programme for babies aged three and four months who would have not had the opportunity to receive the vaccine at two months of age.